tirzepatide suicidal ideation FDA clears GLP-1 weight loss drugs of risk | Hesham Sherif posted on the topic Tirzepatide (Zepbound) for weight loss

10.1016/j.diabres.2021.109118 32 PapamargaritisD.Al-NajimW.LimJ.CraneJ.BodicoatD

One of the promising therapies we offer is semaglutide, a GLP-1 receptor agonist that has gained recognition for its remarkable efficacy in aiding weight loss

Lancet (2021) 398:26276

For most people taking 1,0002,000 mg daily, L-Carnitine is considered safe

In a 48-week clinical trial, higher doses consistently led to greater average weight loss: Weight loss by dose (48-week clinical trial) In this trial, at the highest dose (12 mg), people lost an average 24% of their starting weight on average

GLP-1 drugs can have side effects and may not be right for everyone